Metastasis suppressor function of NM23-H1 requires its 3′-5′ exonuclease activity

Authors

  • Qingbei Zhang,

    1. Department of Molecular and Biomedical Pharmacology, University of Kentucky College of Medicine, Lexington, KY
    2. Markey Cancer Center, University of Kentucky, Lexington, KY
    Current affiliation:
    1. Department of Pathology, University of Chicago, Chicago, IL 60637, USA
    Search for more papers by this author
    • Qingbei Zhang, Joseph R. McCorkle, Marian Novak and Mengmeng Yang contributed equally to this work

  • Joseph R. McCorkle,

    1. Department of Molecular and Biomedical Pharmacology, University of Kentucky College of Medicine, Lexington, KY
    2. Markey Cancer Center, University of Kentucky, Lexington, KY
    Search for more papers by this author
    • Qingbei Zhang, Joseph R. McCorkle, Marian Novak and Mengmeng Yang contributed equally to this work

  • Marian Novak,

    1. Department of Molecular and Biomedical Pharmacology, University of Kentucky College of Medicine, Lexington, KY
    2. Markey Cancer Center, University of Kentucky, Lexington, KY
    Search for more papers by this author
    • Qingbei Zhang, Joseph R. McCorkle, Marian Novak and Mengmeng Yang contributed equally to this work

  • Mengmeng Yang,

    1. Department of Molecular and Biomedical Pharmacology, University of Kentucky College of Medicine, Lexington, KY
    2. Markey Cancer Center, University of Kentucky, Lexington, KY
    Search for more papers by this author
    • Qingbei Zhang, Joseph R. McCorkle, Marian Novak and Mengmeng Yang contributed equally to this work

  • David M. Kaetzel

    Corresponding author
    1. Department of Molecular and Biomedical Pharmacology, University of Kentucky College of Medicine, Lexington, KY
    2. Markey Cancer Center, University of Kentucky, Lexington, KY
    • Department of Molecular and Biomedical Pharmacology, University of Kentucky College of Medicine, 800 Rose Street, MS301, Lexington, KY 40536-0298, USA
    Search for more papers by this author
    • Fax: +1-859-323-1981


  • Conflicts of interest: The authors declare no conflicts of interest.

Abstract

The metastasis suppressor NM23-H1 possesses 3 enzymatic activities in vitro, a nucleoside diphosphate kinase (NDPK), a protein histidine kinase and a more recently characterized 3′-5′ exonuclease. Although the histidine kinase has been implicated in suppression of motility in breast carcinoma cell lines, potential relevance of the NDPK and 3′-5′ exonuclease to metastasis suppressor function has not been addressed in detail. To this end, site-directed mutagenesis and biochemical analyses of bacterially expressed mutant NM23-H1 proteins have identified mutations that disrupt the 3′-5′ exonuclease alone (Glu5 to Ala, or E5A), the NDPK and histidine kinase activities tandemly (Y52A, H118F) or all 3 activities simultaneously (K12Q). Although forced expression of NM23-H1 potently suppressed spontaneous lung metastasis of subcutaneous tumor explants derived from the human melanoma cell line 1205LU, no significant metastasis suppressor activity was obtained with the exonuclease-deficient variants E5A and K12Q. The H118F mutant, which lacked both the NDPK and histidine kinase while retaining the 3′-5′ exonuclease, also exhibited compromised suppressor activity. In contrast, each mutant retained the ability to suppress motility and invasive characteristics of 1205LU cells in culture, indicating that the NM23-H1 molecule possesses an additional activity(s) mediating these suppressor functions. These studies provide the first demonstration that the 3′-5′ exonuclease activity of NM23-H1 is necessary for metastasis suppressor function and further indicate cooperativity of the 3 enzymatic activities of the molecule on suppression of the metastatic process.

Ancillary